株探米国株
日本語 英語
エドガーで原本を確認する
FALSE000073101200007310122025-02-122025-02-12

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 12, 2025

HCSG_Logo No Tagline.jpg

HEALTHCARE SERVICES GROUP, INC.
(Exact name of registrant as specified in its charter)

Commission File Number: 0-12015
Pennsylvania 23-2018365
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification number)

3220 Tillman Drive, Suite 300, Bensalem, Pennsylvania
(Address of principal executive office)

19020
(Zip Code)

Registrant's telephone number, including area code: 215-639-4274
    
Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
( ☐ )    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
( ☐ )    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
( ☐ )    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
( ☐ )    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.01 par value HCSG NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o On February 12, 2025, Healthcare Services Group, Inc. (the “Company”) issued a press release (the “Press Release”) announcing its earnings for the three months and year ended December 31, 2024. A copy of the Press Release is being furnished hereto as Exhibit 99.1 and is hereby incorporated by reference to this Current Report.



Item 2.02 Results of Operations and Financial Condition.


The information furnished herein, including Exhibit 99.1 shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act.

Item 9.01 Financial Statements and Exhibits

( a )    Not applicable
( b )    Not applicable
( c )    Not applicable
( d )    Exhibits.
Exhibit Number Description
99.1
104 Cover page Interactive Data File (embedded within the Inline XBRL document)





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

HEALTHCARE SERVICES GROUP, INC.
Date: February 12, 2025 By: /s/ Vikas Singh
Name: Vikas Singh
Title: Executive Vice President & Chief Financial Officer

EX-99 2 ex99-2024xq4xpressrelease.htm EX-99.1 Document
Exhibit 99.1
HCSG Reports Q4 2024 Results
Delivers Strong Earnings & Cash Flow,
Provides 2025 Growth Expectations

◦Revenue of $437.8 million.
◦Net income and diluted EPS of $11.9 million and $0.16, inclusive of new business start-up costs.
◦Reported cash flow from operations of $36.2 million; actual cash flow from operations, excluding the change in payroll accrual, of $27.0 million.
◦Expects mid-single digit revenue growth in 2025 and Q1 revenue in the range of $440.0 to $450.0 million.
◦Expects 2025 actual cash flow from operations, excluding the change in payroll accrual, in the range of $45.0 to $60.0 million.

BENSALEM, PA--(BUSINESS WIRE)-- Healthcare Services Group, Inc. (NASDAQ:HCSG) today reported results for the three months ended December 31, 2024.

Ted Wahl, Chief Executive Officer, stated, “2024 was a transitional year for HCSG, as it marked a pivotal shift from recovery to renewed growth. This shift was highlighted by our Q4 results and the positive momentum we’re carrying into the new year. Looking ahead, we are confident that continuing to execute on our strategic priorities, supported by our strong business fundamentals, will enable us to further accelerate growth, enhance profitability, and maximize cash flow through 2025 and beyond.”

Fourth Quarter Results

◦Revenue was reported at $437.8 million.
▪Housekeeping & laundry and dining & nutrition segment revenues and margins were $192.7 million and 10.2% and $245.1 million and 4.7%, respectively.
▪The Company expects mid-single digit revenue growth in 2025 and Q1 revenue in the range of $440.0 to $450.0 million.
◦Cost of services was reported at $379.2 million or 86.6%, inclusive of new business start-up costs.
▪The Company’s 2025 goal is to manage cost of services in the 86% range.
◦SG&A was reported at $44.8 million; after adjusting for the $0.4 million increase in deferred compensation, actual SG&A was $44.4 million or 10.1%, inclusive of new business start-up costs.
▪The Company’s 2025 goal is to manage SG&A into the 8.5% to 9.5% range.
◦Net income and diluted EPS were reported at $11.9 million and $0.16, inclusive of new business start-up costs.
◦Cash flow from operations was reported at $36.2 million; after adjusting for the $9.2 million increase in the payroll accrual, actual cash flow from operations was $27.0 million.
▪The Company estimates 2025 actual cash flow from operations, excluding the change in payroll accrual, in the range of $45.0 to $60.0 million.

Balance Sheet and Liquidity

The Company’s primary sources of liquidity are cash flow from operating activities, cash and cash equivalents, and its revolving credit facility. As of the end of the fourth quarter, the Company had cash and marketable securities of $135.8 million and a $500.0 million credit facility, inclusive of its $200.0 million accordion, which expires in November 2027.

Since the February 2023 share repurchase authorization, the Company has repurchased over $16.0 million of its common stock. The Company repurchased over $5.0 million of its common stock in 2024, including $1.0 million during the fourth quarter.


Exhibit 99.1
The Company has 6.0 million shares remaining under its authorization.

Conference Call and Upcoming Events

The Company will host a conference call on Wednesday, February 12, 2025, at 8:30 a.m. Eastern Time to discuss its results for the three months ended December 31, 2024. The call may be accessed via phone at 1 (800) 715-9871, Conference ID: 9951274. The call will be simultaneously webcast under the “Events & Presentations” section of the Investor Relations page on the Company’s website, www.hcsg.com. A replay of the webcast will also be available on the website for one year following the date of the earnings call.

The Company will be participating in Oppenheimer’s 35th Annual Healthcare MedTech & Services Conference, which will be conducted virtually on March 19, 2025.

About Healthcare Services Group, Inc.

Healthcare Services Group (NASDAQ: HCSG) is an experienced leader in managing housekeeping, laundry, dining, and nutritional services within the healthcare industry. With more than 45 years of experience, HCSG aims to provide improved operational, regulatory, and financial outcomes for our clients.








Exhibit 99.1
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This release and any schedules incorporated by reference into it may contain forward-looking statements within the meaning of federal securities laws, which are not historical facts but rather are based on current expectations, estimates and projections about our business and industry, and our beliefs and assumptions. Words such as “believes,” “anticipates,” “plans,” “expects,” “estimates,” “will,” “goal,” and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Such forward-looking information is also subject to various risks and uncertainties. Such risks and uncertainties include, but are not limited to, risks arising from our providing services to the healthcare industry and primarily providers of long-term care; credit and collection risks associated with the healthcare industry; the impact of bank failures; our claims experience related to workers’ compensation, general liability and auto insurance; the effects of changes in, or interpretations of laws and regulations governing the healthcare industry, our workforce and services provided, including state and local regulations pertaining to the taxability of our services and other labor-related matters such as minimum wage increases; the Company’s expectations with respect to selling, general and administrative expense; the impacts of past or future cyber attacks or breaches; and the risk factors described in Part I of our Form 10-K for the fiscal year ended December 31, 2023 under “Government Regulation of Customers,” “Service Agreements and Collections,” and “Competition” and under Item IA. “Risk Factors” in such Form 10K.

These factors, in addition to delays in payments from customers and/or customers undergoing restructurings, have resulted in, and could continue to result in, significant additional bad debts in the near future. Additionally, our operating results have been in the past and could in the future be adversely affected by continued inflation particularly if increases in the costs of labor and labor-related costs, materials, supplies and equipment used in performing services (including the impact of potential tariffs) cannot be passed on to our customers.

In addition, we believe that to improve our financial performance we must continue to obtain service agreements with new customers, retain and provide new services to existing customers, achieve modest price increases on current service agreements with existing customers and/or maintain internal cost reduction strategies at our various operational levels. Furthermore, we believe that our ability to sustain the internal development of managerial personnel is an important factor impacting future operating results and the successful execution of our projected growth strategies. There can be no assurance that we will be successful in that regard.

USE OF NON-GAAP FINANCIAL INFORMATION

To supplement HCSG’s consolidated financial information, which are prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”), the Company believes that certain non-GAAP financial measures are useful in evaluating operating performance and comparing such performance to other companies.

The Company is presenting adjusted cash flows provided by operations, earnings before interest, taxes, depreciation and amortization (“EBITDA”) and EBITDA excluding items impacting comparability (“Adjusted EBITDA”). We cannot provide a reconciliation of forward-looking non-GAAP measures to GAAP due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. The presentation of non-GAAP financial measures is not meant to be considered in isolation or as a substitute for financial statements prepared in accordance with GAAP.

Company Contacts:
Theodore Wahl
President and Chief Executive Officer
Vikas Singh
Executive Vice President and Chief Financial Officer
Matthew J. McKee
Chief Communications Officer
215-639-4274
investor-relations@hcsgcorp.com



Exhibit 99.1
HEALTHCARE SERVICES GROUP, INC.
CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
(in thousands, except per share data)

For the Three Months Ended For the Year Ended
December 31, December 31,
2024 2023 2024 2023
Revenue $ 437,812  $ 423,840  $ 1,715,682  $ 1,671,389 
Operating costs and expenses:
Cost of services 379,209  349,124  1,487,592  1,456,643 
Selling, general and administrative 44,824  46,249  183,060  166,772 
Income from operations 13,779  28,467  45,030  47,974 
Other income, net 1,026  3,833  7,911  5,082 
Income before income taxes 14,805  32,300  52,941  53,056 
Income tax provision 2,885  8,792  13,470  14,670 
Net income $ 11,920  $ 23,508  $ 39,471  $ 38,386 
Basic earnings per common share $ 0.16  $ 0.32  $ 0.54  $ 0.52 
Diluted earnings per common share $ 0.16  $ 0.32  $ 0.53  $ 0.52 
Basic weighted average number of common shares outstanding 73,553  73,817  73,754  74,288 
Diluted weighted average number of common shares outstanding 73,934  73,879  73,988  74,340 




Exhibit 99.1
HEALTHCARE SERVICES GROUP, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(in thousands)
December 31, 2024 December 31, 2023
Cash and cash equivalents $ 56,776  $ 54,330 
Restricted cash equivalents 3,355  — 
Marketable securities, at fair value 50,535  93,131 
Restricted marketable securities, at fair value 25,105  — 
Accounts receivable, net 330,907  344,864 
Notes receivable, net 51,429  38,645 
Other current assets 38,545  40,726 
Total current assets 556,652  571,696 
Property and equipment, net 28,198  28,774 
Notes receivable — long-term, net 41,054  24,832 
Goodwill 75,529  75,529 
Other intangible assets, net 9,442  12,127 
Deferred compensation funding 49,639  40,812 
Other assets 42,258  36,882 
Total assets $ 802,772  $ 790,652 
Accrued insurance claims — current $ 25,148  $ 22,681 
Other current liabilities 167,399  194,247 
Total current liabilities 192,547  216,928 
Accrued insurance claims — long-term 51,869  61,697 
Deferred compensation liability — long-term 50,011  41,186 
Lease liability — long-term 8,033  11,235 
Other long-term liabilities 385  2,990 
Stockholders’ equity 499,927  456,616 
Total liabilities and stockholders’ equity $ 802,772  $ 790,652 







Exhibit 99.1
HEALTHCARE SERVICES GROUP, INC.
RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES
(Unaudited)

Reconciliation of GAAP net income to EBITDA and adjusted EBITDA (in thousands) For the Three Months Ended For the Year Ended
December 31, December 31,
2024 2023 2024 2023
GAAP net income $ 11,920  $ 23,508  $ 39,471  $ 38,386 
Income tax provision 2,885  8,792  13,470  14,670 
Interest, net (555) 509  (424) 1,629 
Depreciation and amortization1
3,602  3,779  14,585  14,344 
EBITDA $ 17,852  $ 36,588  $ 67,102  $ 69,029 
Share-based compensation 2,337  2,192  9,165  8,985 
(Gain)/loss on deferred compensation, net2
(12) (28) (52) 39 
Adjusted EBITDA $ 20,177  $ 38,752  $ 76,215  $ 78,053 
Adjusted EBITDA as a percentage of revenue 4.6  % 9.1  % 4.4  % 4.7  %

Reconciliation of GAAP cash flows provided by operations to adjusted cash flows provided by operations (in thousands) For the Three Months Ended For the Year Ended
December 31, December 31,
2024 2023 2024 2023
GAAP cash flows provided by operations $ 36,204  $ 49,445  $ 30,802  $ 43,498 
Accrued payroll3
(9,247) (21,563) 3,573  (4,186)
Adjusted cash flows provided by operations $ 26,957  $ 27,882  $ 34,375  $ 39,312 
1.Includes right-of-use asset depreciation of $2.0 million and $7.8 million for the three and twelve months ended December 31, 2024, respectively, and $1.8 million and $6.4 million for the three and twelve months ended December 31, 2023.
2.The Company offers a Supplemental Executive Retirement Plan (“SERP”) for executives and certain key employees which is also referred to as the Company’s “Deferred Compensation” plan. For SERP participants, the Company has historically retained, and anticipates continuing to retain, 100% of the funds received from SERP participants and holds such assets (the “Deferred Compensation Assets”) in a brokerage account where the investments are managed to mirror the investment elections of SERP participant holdings under such plans (the “Deferred Compensation Liabilities”). The Company’s changes in fair market value of the Deferred Compensation Assets are presented under the “Other income, net” caption on the Company’s Consolidated Statements of Comprehensive Income, however the corresponding and offsetting changes in the fair market value of the Deferred Compensation Liabilities are presented under the “Selling, general and administrative expense” caption.
3.The accrued payroll adjustment reflects changes in accrued payroll for the three and twelve months ended December 31, 2024 and 2023. The Company processes payroll on set weekly and bi-weekly schedules, and the timing of payments may result in operating cash flow increases or decreases which are not indicative of the Company’s quarterly cash flow performance.